 Elaine Morrato
Concepts (289)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Antipsychotic Agents | 15 | 2021 | 184 | 5.070 |
Why?
| | Medicaid | 14 | 2022 | 407 | 2.640 |
Why?
| | Drug-Related Side Effects and Adverse Reactions | 7 | 2021 | 243 | 2.070 |
Why?
| | Schizophrenia | 6 | 2021 | 415 | 1.910 |
Why?
| | Blood Glucose | 11 | 2016 | 1821 | 1.560 |
Why?
| | Lipids | 6 | 2016 | 582 | 1.430 |
Why?
| | United States Food and Drug Administration | 10 | 2023 | 172 | 1.340 |
Why?
| | Risk Management | 4 | 2020 | 89 | 1.260 |
Why?
| | Practice Patterns, Physicians' | 12 | 2017 | 1177 | 1.240 |
Why?
| | United States | 42 | 2023 | 12211 | 1.100 |
Why?
| | Developmental Disabilities | 2 | 2020 | 239 | 1.090 |
Why?
| | Diabetes Mellitus | 8 | 2021 | 904 | 0.970 |
Why?
| | Risk Evaluation and Mitigation | 2 | 2021 | 2 | 0.950 |
Why?
| | Prescription Drugs | 3 | 2022 | 116 | 0.940 |
Why?
| | Missouri | 8 | 2016 | 62 | 0.930 |
Why?
| | Pharmaceutical Preparations | 3 | 2023 | 169 | 0.910 |
Why?
| | Mental Disorders | 7 | 2015 | 891 | 0.840 |
Why?
| | Drug Prescriptions | 5 | 2016 | 239 | 0.790 |
Why?
| | Mass Screening | 4 | 2016 | 1011 | 0.790 |
Why?
| | State Government | 1 | 2022 | 41 | 0.780 |
Why?
| | Risk Assessment | 7 | 2023 | 2975 | 0.770 |
Why?
| | Patient Protection and Affordable Care Act | 1 | 2022 | 99 | 0.740 |
Why?
| | Insurance Coverage | 1 | 2022 | 202 | 0.700 |
Why?
| | Depression, Postpartum | 1 | 2022 | 103 | 0.700 |
Why?
| | Caregivers | 3 | 2022 | 714 | 0.630 |
Why?
| | Comparative Effectiveness Research | 3 | 2014 | 130 | 0.620 |
Why?
| | Humans | 68 | 2023 | 114935 | 0.620 |
Why?
| | Program Evaluation | 3 | 2023 | 824 | 0.610 |
Why?
| | Antidepressive Agents, Second-Generation | 2 | 2009 | 38 | 0.610 |
Why?
| | State Health Plans | 2 | 2016 | 32 | 0.610 |
Why?
| | Stroke Rehabilitation | 1 | 2018 | 34 | 0.610 |
Why?
| | Periodontal Diseases | 2 | 2015 | 57 | 0.590 |
Why?
| | Child Health Services | 1 | 2019 | 177 | 0.580 |
Why?
| | Physician-Patient Relations | 2 | 2014 | 463 | 0.560 |
Why?
| | Drug Utilization Review | 2 | 2014 | 57 | 0.540 |
Why?
| | Community Mental Health Services | 2 | 2016 | 84 | 0.520 |
Why?
| | Information Dissemination | 2 | 2015 | 188 | 0.520 |
Why?
| | Community Mental Health Centers | 1 | 2015 | 13 | 0.510 |
Why?
| | Paliperidone Palmitate | 1 | 2014 | 4 | 0.480 |
Why?
| | Advisory Committees | 4 | 2012 | 208 | 0.480 |
Why?
| | Risk | 2 | 2018 | 815 | 0.470 |
Why?
| | Dyslipidemias | 3 | 2010 | 154 | 0.460 |
Why?
| | Quality Control | 1 | 2014 | 144 | 0.460 |
Why?
| | Cohort Studies | 12 | 2020 | 4903 | 0.460 |
Why?
| | Bipolar Disorder | 1 | 2016 | 205 | 0.460 |
Why?
| | Patient Care | 1 | 2014 | 103 | 0.450 |
Why?
| | Diabetes Mellitus, Type 2 | 5 | 2011 | 2096 | 0.430 |
Why?
| | Health Services Research | 2 | 2015 | 371 | 0.430 |
Why?
| | Universities | 1 | 2015 | 339 | 0.430 |
Why?
| | Primary Health Care | 3 | 2020 | 1515 | 0.420 |
Why?
| | Physicians' Offices | 1 | 2012 | 16 | 0.420 |
Why?
| | Focus Groups | 1 | 2014 | 385 | 0.410 |
Why?
| | Physician's Role | 1 | 2014 | 198 | 0.410 |
Why?
| | Malpractice | 1 | 2012 | 37 | 0.410 |
Why?
| | Parents | 2 | 2019 | 1191 | 0.410 |
Why?
| | Injections | 3 | 2021 | 159 | 0.410 |
Why?
| | Anti-Obesity Agents | 1 | 2012 | 45 | 0.400 |
Why?
| | Female | 31 | 2022 | 59580 | 0.400 |
Why?
| | Drug Approval | 1 | 2012 | 78 | 0.400 |
Why?
| | Adolescent | 21 | 2016 | 17829 | 0.390 |
Why?
| | Drug Monitoring | 2 | 2010 | 184 | 0.380 |
Why?
| | Adult | 21 | 2022 | 30608 | 0.380 |
Why?
| | Patient Safety | 1 | 2014 | 278 | 0.380 |
Why?
| | Health Care Costs | 1 | 2014 | 380 | 0.370 |
Why?
| | Retrospective Studies | 15 | 2020 | 12544 | 0.370 |
Why?
| | Quality Improvement | 4 | 2020 | 954 | 0.370 |
Why?
| | Multivariate Analysis | 7 | 2015 | 1440 | 0.360 |
Why?
| | Middle Aged | 18 | 2022 | 26806 | 0.360 |
Why?
| | Male | 29 | 2021 | 55663 | 0.360 |
Why?
| | Hospitalization | 3 | 2014 | 1754 | 0.360 |
Why?
| | Hyperglycemia | 2 | 2011 | 292 | 0.350 |
Why?
| | Databases, Factual | 8 | 2014 | 1125 | 0.350 |
Why?
| | Risk Factors | 13 | 2015 | 8637 | 0.340 |
Why?
| | Managed Care Programs | 3 | 2009 | 133 | 0.340 |
Why?
| | Medication Adherence | 1 | 2014 | 537 | 0.340 |
Why?
| | Polypharmacy | 2 | 2007 | 74 | 0.330 |
Why?
| | Cardiovascular Diseases | 4 | 2015 | 1729 | 0.330 |
Why?
| | Hyperlipidemias | 1 | 2010 | 122 | 0.330 |
Why?
| | Insurance Claim Review | 2 | 2021 | 67 | 0.320 |
Why?
| | Practice Guidelines as Topic | 2 | 2014 | 1400 | 0.320 |
Why?
| | Administration, Oral | 3 | 2016 | 731 | 0.310 |
Why?
| | Neoplasms | 4 | 2023 | 2106 | 0.310 |
Why?
| | Logistic Models | 5 | 2015 | 1844 | 0.300 |
Why?
| | General Surgery | 2 | 2013 | 126 | 0.300 |
Why?
| | Office Visits | 1 | 2007 | 79 | 0.290 |
Why?
| | Delayed-Action Preparations | 2 | 2021 | 159 | 0.290 |
Why?
| | Emergency Medical Services | 1 | 2014 | 587 | 0.290 |
Why?
| | Pemoline | 1 | 2007 | 5 | 0.280 |
Why?
| | Policy Making | 1 | 2007 | 81 | 0.280 |
Why?
| | Dementia | 2 | 2021 | 186 | 0.280 |
Why?
| | Cross-Sectional Studies | 5 | 2023 | 4407 | 0.280 |
Why?
| | Metabolic Syndrome | 2 | 2011 | 323 | 0.270 |
Why?
| | Data Collection | 3 | 2008 | 623 | 0.270 |
Why?
| | Health Policy | 3 | 2007 | 334 | 0.260 |
Why?
| | Exercise | 2 | 2007 | 1643 | 0.260 |
Why?
| | Electronic Health Records | 1 | 2012 | 802 | 0.260 |
Why?
| | Guideline Adherence | 1 | 2010 | 490 | 0.260 |
Why?
| | Child | 17 | 2022 | 18366 | 0.260 |
Why?
| | Physical Fitness | 1 | 2007 | 179 | 0.250 |
Why?
| | California | 4 | 2010 | 363 | 0.250 |
Why?
| | Medicare | 2 | 2021 | 666 | 0.240 |
Why?
| | Communication | 3 | 2022 | 749 | 0.240 |
Why?
| | Young Adult | 9 | 2016 | 10478 | 0.230 |
Why?
| | Fee-for-Service Plans | 3 | 2021 | 83 | 0.230 |
Why?
| | Diabetes Mellitus, Type 1 | 3 | 2015 | 3248 | 0.230 |
Why?
| | Drug Labeling | 3 | 2010 | 42 | 0.230 |
Why?
| | Obesity | 3 | 2012 | 2514 | 0.230 |
Why?
| | Infant | 5 | 2020 | 7937 | 0.220 |
Why?
| | Diabetes Complications | 4 | 2011 | 211 | 0.220 |
Why?
| | Aged, 80 and over | 8 | 2018 | 6364 | 0.220 |
Why?
| | Evidence-Based Medicine | 1 | 2007 | 675 | 0.220 |
Why?
| | Specialties, Surgical | 3 | 2013 | 70 | 0.220 |
Why?
| | Small-Area Analysis | 2 | 2014 | 8 | 0.210 |
Why?
| | Aged | 13 | 2021 | 19122 | 0.200 |
Why?
| | Treatment Outcome | 5 | 2021 | 9105 | 0.200 |
Why?
| | Age Factors | 4 | 2019 | 2891 | 0.200 |
Why?
| | Child, Preschool | 7 | 2019 | 9086 | 0.190 |
Why?
| | Diffusion of Innovation | 2 | 2013 | 94 | 0.190 |
Why?
| | Stakeholder Participation | 1 | 2022 | 73 | 0.190 |
Why?
| | Public Health | 3 | 2023 | 434 | 0.180 |
Why?
| | Mental Status and Dementia Tests | 1 | 2021 | 21 | 0.180 |
Why?
| | Spinal Fusion | 2 | 2013 | 210 | 0.170 |
Why?
| | Oregon | 2 | 2010 | 66 | 0.170 |
Why?
| | Information Storage and Retrieval | 1 | 2020 | 108 | 0.160 |
Why?
| | Delivery of Health Care | 2 | 2023 | 834 | 0.160 |
Why?
| | Surgical Procedures, Operative | 2 | 2013 | 206 | 0.160 |
Why?
| | Mentors | 2 | 2023 | 158 | 0.160 |
Why?
| | Nootropic Agents | 1 | 2018 | 27 | 0.160 |
Why?
| | Professional-Family Relations | 1 | 2019 | 132 | 0.160 |
Why?
| | Health Services Accessibility | 2 | 2022 | 765 | 0.150 |
Why?
| | Pediatrics | 4 | 2017 | 984 | 0.150 |
Why?
| | Medicare Part D | 1 | 2018 | 26 | 0.150 |
Why?
| | Recurrence | 1 | 2021 | 937 | 0.150 |
Why?
| | Severity of Illness Index | 2 | 2019 | 2542 | 0.150 |
Why?
| | Social Networking | 1 | 2018 | 31 | 0.150 |
Why?
| | Curriculum | 2 | 2015 | 845 | 0.150 |
Why?
| | Time-to-Treatment | 1 | 2019 | 147 | 0.150 |
Why?
| | Checklist | 1 | 2018 | 84 | 0.140 |
Why?
| | Suicide | 3 | 2007 | 502 | 0.140 |
Why?
| | Odds Ratio | 3 | 2015 | 954 | 0.140 |
Why?
| | Cancer Survivors | 1 | 2021 | 206 | 0.140 |
Why?
| | Drug and Narcotic Control | 2 | 2007 | 29 | 0.140 |
Why?
| | Health Priorities | 1 | 2017 | 34 | 0.140 |
Why?
| | Preventive Health Services | 1 | 2018 | 135 | 0.140 |
Why?
| | Evidence-Based Practice | 1 | 2018 | 185 | 0.140 |
Why?
| | Monitoring, Physiologic | 2 | 2009 | 248 | 0.130 |
Why?
| | Mental Health | 3 | 2011 | 559 | 0.130 |
Why?
| | Indians, North American | 1 | 2021 | 570 | 0.130 |
Why?
| | Urban Population | 1 | 2019 | 402 | 0.130 |
Why?
| | Birth Weight | 1 | 2019 | 440 | 0.130 |
Why?
| | Hospitals, Pediatric | 3 | 2013 | 479 | 0.130 |
Why?
| | Societies, Medical | 2 | 2010 | 677 | 0.130 |
Why?
| | Poverty | 1 | 2019 | 443 | 0.120 |
Why?
| | Referral and Consultation | 1 | 2020 | 634 | 0.120 |
Why?
| | Case Management | 1 | 2015 | 62 | 0.120 |
Why?
| | Time Factors | 3 | 2014 | 6125 | 0.120 |
Why?
| | Patient-Centered Care | 3 | 2018 | 473 | 0.120 |
Why?
| | Analgesics, Opioid | 1 | 2022 | 773 | 0.120 |
Why?
| | Spatial Analysis | 1 | 2014 | 20 | 0.120 |
Why?
| | Research Support as Topic | 1 | 2015 | 108 | 0.120 |
Why?
| | Prevalence | 4 | 2008 | 2252 | 0.120 |
Why?
| | Hospitals, General | 1 | 2013 | 19 | 0.110 |
Why?
| | Bias | 1 | 2014 | 180 | 0.110 |
Why?
| | Patient Care Team | 1 | 2018 | 516 | 0.110 |
Why?
| | Socioeconomic Factors | 3 | 2018 | 1081 | 0.110 |
Why?
| | Home Nursing | 1 | 2013 | 26 | 0.110 |
Why?
| | Insurance, Liability | 1 | 2012 | 6 | 0.110 |
Why?
| | Healthcare Disparities | 1 | 2018 | 480 | 0.110 |
Why?
| | Organizational Objectives | 1 | 2013 | 69 | 0.110 |
Why?
| | Organizational Case Studies | 1 | 2012 | 69 | 0.100 |
Why?
| | Attitude of Health Personnel | 1 | 2019 | 978 | 0.100 |
Why?
| | Liability, Legal | 1 | 2012 | 38 | 0.100 |
Why?
| | Classification | 1 | 2012 | 19 | 0.100 |
Why?
| | Oral Hygiene | 1 | 2011 | 18 | 0.100 |
Why?
| | Sex Factors | 2 | 2007 | 1721 | 0.100 |
Why?
| | Disease Management | 1 | 2015 | 563 | 0.100 |
Why?
| | Mentally Ill Persons | 1 | 2011 | 13 | 0.100 |
Why?
| | Models, Organizational | 1 | 2012 | 140 | 0.090 |
Why?
| | Biomedical Research | 1 | 2017 | 585 | 0.090 |
Why?
| | Fundoplication | 1 | 2011 | 51 | 0.090 |
Why?
| | Educational Status | 3 | 2011 | 409 | 0.090 |
Why?
| | Interprofessional Relations | 1 | 2013 | 251 | 0.090 |
Why?
| | Laparotomy | 1 | 2011 | 96 | 0.090 |
Why?
| | Body Mass Index | 3 | 2007 | 1961 | 0.090 |
Why?
| | Interviews as Topic | 1 | 2013 | 582 | 0.090 |
Why?
| | Triglycerides | 2 | 2011 | 470 | 0.090 |
Why?
| | Matched-Pair Analysis | 1 | 2010 | 33 | 0.090 |
Why?
| | Pregnancy | 1 | 2022 | 5527 | 0.090 |
Why?
| | Perception | 1 | 2012 | 311 | 0.090 |
Why?
| | Specialization | 2 | 2007 | 115 | 0.090 |
Why?
| | Benchmarking | 1 | 2011 | 161 | 0.080 |
Why?
| | Patient Satisfaction | 1 | 2013 | 583 | 0.080 |
Why?
| | Medicine | 2 | 2007 | 102 | 0.080 |
Why?
| | Consensus Development Conferences as Topic | 1 | 2009 | 28 | 0.080 |
Why?
| | Glucose Tolerance Test | 1 | 2010 | 343 | 0.080 |
Why?
| | Psychotic Disorders | 1 | 2010 | 118 | 0.080 |
Why?
| | Surgical Wound Infection | 1 | 2011 | 248 | 0.080 |
Why?
| | Comorbidity | 2 | 2010 | 1458 | 0.080 |
Why?
| | Tennessee | 1 | 2008 | 38 | 0.080 |
Why?
| | Utah | 1 | 2008 | 60 | 0.080 |
Why?
| | Medical Audit | 1 | 2008 | 75 | 0.080 |
Why?
| | Legislation, Medical | 1 | 2007 | 10 | 0.070 |
Why?
| | Health Surveys | 2 | 2007 | 443 | 0.070 |
Why?
| | State Medicine | 1 | 2007 | 18 | 0.070 |
Why?
| | Risk Adjustment | 1 | 2008 | 75 | 0.070 |
Why?
| | Evaluation Studies as Topic | 1 | 2007 | 168 | 0.070 |
Why?
| | Appointments and Schedules | 1 | 2007 | 73 | 0.070 |
Why?
| | Cholesterol | 1 | 2009 | 368 | 0.070 |
Why?
| | Clozapine | 1 | 2007 | 19 | 0.070 |
Why?
| | United Kingdom | 1 | 2007 | 227 | 0.070 |
Why?
| | Laparoscopy | 1 | 2011 | 389 | 0.070 |
Why?
| | Insurance, Pharmaceutical Services | 1 | 2007 | 23 | 0.070 |
Why?
| | Australia | 1 | 2007 | 207 | 0.070 |
Why?
| | Product Surveillance, Postmarketing | 1 | 2007 | 63 | 0.070 |
Why?
| | Follow-Up Studies | 3 | 2011 | 4427 | 0.070 |
Why?
| | Decision Making | 1 | 2012 | 781 | 0.070 |
Why?
| | Waiting Lists | 1 | 2007 | 211 | 0.060 |
Why?
| | Quality Assurance, Health Care | 1 | 2008 | 313 | 0.060 |
Why?
| | Immunization Programs | 1 | 2007 | 206 | 0.060 |
Why?
| | Central Nervous System Stimulants | 1 | 2007 | 139 | 0.060 |
Why?
| | Depressive Disorder | 1 | 2007 | 332 | 0.060 |
Why?
| | Depressive Disorder, Major | 1 | 2007 | 300 | 0.060 |
Why?
| | Drug Therapy, Combination | 1 | 2007 | 954 | 0.060 |
Why?
| | Coronary Disease | 1 | 2006 | 347 | 0.060 |
Why?
| | Incidence | 1 | 2010 | 2316 | 0.060 |
Why?
| | Proportional Hazards Models | 1 | 2007 | 1080 | 0.060 |
Why?
| | Quality of Health Care | 1 | 2008 | 573 | 0.060 |
Why?
| | Diabetic Angiopathies | 1 | 2005 | 244 | 0.050 |
Why?
| | Colorado | 1 | 2012 | 4091 | 0.050 |
Why?
| | Counseling | 1 | 2006 | 342 | 0.050 |
Why?
| | Alaska | 1 | 2021 | 78 | 0.050 |
Why?
| | South Carolina | 2 | 2011 | 40 | 0.050 |
Why?
| | Postoperative Complications | 2 | 2011 | 2133 | 0.050 |
Why?
| | Patient Education as Topic | 1 | 2006 | 678 | 0.050 |
Why?
| | Substance-Related Disorders | 1 | 2009 | 946 | 0.050 |
Why?
| | Survivorship | 1 | 2021 | 39 | 0.050 |
Why?
| | Medical Oncology | 1 | 2022 | 228 | 0.040 |
Why?
| | Europe | 1 | 2020 | 336 | 0.040 |
Why?
| | Surveys and Questionnaires | 2 | 2022 | 4635 | 0.040 |
Why?
| | Students | 1 | 2023 | 500 | 0.040 |
Why?
| | Independent Living | 1 | 2018 | 84 | 0.040 |
Why?
| | Residence Characteristics | 1 | 2018 | 275 | 0.030 |
Why?
| | Pharmacoepidemiology | 1 | 2015 | 20 | 0.030 |
Why?
| | Health Promotion | 1 | 2022 | 686 | 0.030 |
Why?
| | Global Health | 1 | 2015 | 288 | 0.030 |
Why?
| | Cost-Benefit Analysis | 1 | 2015 | 546 | 0.030 |
Why?
| | Health Planning Guidelines | 1 | 2012 | 25 | 0.030 |
Why?
| | Radiography, Bitewing | 1 | 2011 | 2 | 0.030 |
Why?
| | Gingival Hemorrhage | 1 | 2011 | 3 | 0.020 |
Why?
| | Dental Devices, Home Care | 1 | 2011 | 4 | 0.020 |
Why?
| | Toothbrushing | 1 | 2011 | 6 | 0.020 |
Why?
| | Alveolar Bone Loss | 1 | 2011 | 10 | 0.020 |
Why?
| | Periodontal Attachment Loss | 1 | 2011 | 11 | 0.020 |
Why?
| | Mouthwashes | 1 | 2011 | 12 | 0.020 |
Why?
| | Xerostomia | 1 | 2011 | 19 | 0.020 |
Why?
| | Chronic Disease | 1 | 2018 | 1593 | 0.020 |
Why?
| | Accreditation | 1 | 2012 | 78 | 0.020 |
Why?
| | Dental Care | 1 | 2011 | 29 | 0.020 |
Why?
| | Certification | 1 | 2012 | 89 | 0.020 |
Why?
| | Income | 1 | 2011 | 167 | 0.020 |
Why?
| | Infant, Newborn | 2 | 2013 | 5035 | 0.020 |
Why?
| | Confidence Intervals | 1 | 2011 | 309 | 0.020 |
Why?
| | Community Networks | 1 | 2011 | 54 | 0.020 |
Why?
| | C-Peptide | 1 | 2011 | 138 | 0.020 |
Why?
| | Statistics, Nonparametric | 1 | 2011 | 387 | 0.020 |
Why?
| | Health Care Surveys | 1 | 2011 | 539 | 0.020 |
Why?
| | Pain Measurement | 1 | 2011 | 446 | 0.020 |
Why?
| | Regression Analysis | 1 | 2011 | 947 | 0.020 |
Why?
| | Qualitative Research | 1 | 2013 | 936 | 0.020 |
Why?
| | Population Surveillance | 1 | 2011 | 392 | 0.020 |
Why?
| | Statistics as Topic | 1 | 2009 | 294 | 0.020 |
Why?
| | Education, Medical, Graduate | 1 | 2012 | 374 | 0.020 |
Why?
| | Mental Health Services | 1 | 2011 | 317 | 0.020 |
Why?
| | Patient Discharge | 1 | 2013 | 769 | 0.020 |
Why?
| | Length of Stay | 1 | 2011 | 949 | 0.020 |
Why?
| | National Health Programs | 1 | 2006 | 20 | 0.020 |
Why?
| | Pilot Projects | 1 | 2011 | 1372 | 0.020 |
Why?
| | Drug Utilization | 1 | 2007 | 167 | 0.020 |
Why?
| | Health Behavior | 1 | 2011 | 704 | 0.020 |
Why?
| | Physicians, Family | 1 | 2007 | 201 | 0.020 |
Why?
| | Quality Indicators, Health Care | 1 | 2008 | 287 | 0.020 |
Why?
| | Clinical Competence | 1 | 2012 | 901 | 0.020 |
Why?
| | Seasons | 1 | 2007 | 449 | 0.020 |
Why?
| | Survival Analysis | 1 | 2008 | 1220 | 0.020 |
Why?
| | Psychiatry | 1 | 2007 | 154 | 0.010 |
Why?
| | Survival Rate | 1 | 2008 | 1644 | 0.010 |
Why?
| | Life Style | 1 | 2005 | 430 | 0.010 |
Why?
| | Motor Activity | 1 | 2005 | 642 | 0.010 |
Why?
| | Prospective Studies | 1 | 2011 | 6218 | 0.010 |
Why?
|
|
Morrato's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|